Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Marksans Pharma Ltd.

Price on BSE   26 Feb,15:29 LIVE
176.65
+1.15
(+0.66%)

© 2026 Rediff.com
  • Volume :
  • 46,003.00
  • Prev Close :
  • 175.50
  • Day's H/L (Rs.) :
  • 182.00 - 174.45
  • 52wk H/L (Rs.) :
  • 270.60 - 157.25
  • Mkt Cap (Rs. Cr) :
  • 8,005.78
Price on NSE   26 Feb,15:59 LIVE
176.81
+0.95
(+0.54%)

© 2026 Rediff.com
  • Volume :
  • 1,015,945.00
  • Prev Close :
  • 175.86
  • Day's H/L (Rs.) :
  • 182.00 - 175.41
  • 52wk H/L (Rs.) :
  • 270.70 - 156.00
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Marksans Pharma Ltd.
PE Ratios
42.52
EPS (Rs.)
4.15
Sales (Rs. Cr)
339.73
Face Value (Rs.)
1
Net Profit Margin(%)
16.03
Last Bonus
-
Last Dividend(%)
80
Return on Average Equity
13.6

News for Marksans Pharma Ltd.

Unifi Capital Sells Marksans Pharma Stake
Unifi Capital sold a 1.6% stake in Marksans Pharma for nearly Rs 168 crore through an open market transaction. The shares were sold at an average price of Rs 231.50 apiece.
Jul 28, 2025 20:10
OrbiMed Sells Marksans Pharma Stake for Rs 257 Cr
OrbiMed divested a 2.27% stake in Marksans Pharma for Rs 257 crore through an open market transaction. The sale reduced OrbiMed's holding to 8.61%.
Jun 11, 2025 22:28
Pharma Stocks Sink Amid US Tariff Threat
Indian pharma stocks plunged on Wednesday following reports that the US will soon announce tariffs on pharmaceutical imports. Blue Jet Healthcare, Marksans Pharma, Wockhardt, Glenmark...
Apr 09, 2025 17:55
Pharma Stocks Plunge on Trump Tariff Threat
Pharmaceutical stocks tumbled up to 10% after reports of Trump imposing tariffs on imports. Aurobindo, Laurus, Ipca, Lupin, Biocon, and Cipla were among the hardest hit.
Apr 04, 2025 12:03
Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment
Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.
Nov 22, 2024 17:30

More News for Marksans Pharma Ltd. »

News for Pharmaceuticals and health care

UP Govt & German Firm Sign Rs 200 Cr Infra Deal
Uttar Pradesh govt inks Rs 200 crore MoU with German rail infrastructure firm RAILONE GmbH to boost modern infrastructure in the state.
Feb 27, 2026 00:05
BSNL UP Officers Transfer: Controversy & Fallout
BSNL officers in UP face transfer orders over a controversial visit plan. Details on the cancelled visit, reactions, and ongoing inquiry.
Feb 26, 2026 22:22
Crisil Launches GenAI Platform i360
Crisil Intelligence launches i360, a GenAI platform for research, data, and analytics. Get actionable intelligence instantly.
Feb 26, 2026 22:08
NSIC Upgraded to Schedule A Enterprise
NSIC upgraded to Schedule A CPSE by MSME Ministry. This recognition boosts NSIC's support for MSMEs through various interventions.
Feb 26, 2026 22:00
NFRA to Issue Audit Firm Inspection Reports
NFRA will issue inspection reports of 10 audit firms by fiscal year end. Focus on financial reporting, auditing lapses, and SQC compliance.
Feb 26, 2026 21:54

More News »

Top News

UP Govt & German Firm Sign Rs 200 Cr Infra Deal
Uttar Pradesh govt inks Rs 200 crore MoU with German rail infrastructure firm RAILONE GmbH to boost modern infrastructure in the state.
Feb 27, 2026 00:05
BSNL UP Officers Transfer: Controversy & Fallout
BSNL officers in UP face transfer orders over a controversial visit plan. Details on the cancelled visit, reactions, and ongoing inquiry.
Feb 26, 2026 22:22
Crisil Launches GenAI Platform i360
Crisil Intelligence launches i360, a GenAI platform for research, data, and analytics. Get actionable intelligence instantly.
Feb 26, 2026 22:08
Goyal, Lutnick Discuss US-India Trade & Partnership
Piyush Goyal and Howard Lutnick discuss expanding US-India trade after US court ruling on Trump tariffs. Focus on bilateral agreement.
Feb 26, 2026 22:04
NSIC Upgraded to Schedule A Enterprise
NSIC upgraded to Schedule A CPSE by MSME Ministry. This recognition boosts NSIC's support for MSMEs through various interventions.
Feb 26, 2026 22:00

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com